By Habiba Syed, Contributing Reporter
Fujifilm Medical Systems announced its entry into the U.S. CT market by unveiling the FCT Embrace at the 2018 ASTRO annual meeting this past Sunday. The new system, combined with other market-leading oncology solutions, is designed to provide enhanced and efficient CT simulation with radiotherapy treatment planning capabilities.
It is the world’s first 85cm wide bore CT imaging unit to perform at 64- or 128-slice configurations, optimizing both oncology and radiology applications.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
“With advanced image processing, higher rotational speed, wider detector coverage, and greater noise reduction, the FCT Embrace provides exceptional detail for greater clinical confidence,” said senior marketing director, Rick Banner.
The system is designed to serve oncology care providers such as radiation therapists, who will utilize the easy-to-use touch screen, and radiation oncologists who will experience better image quality with the high slice count options.
According to Fujifilm, when compared to a standard wide bore system, the FCT Embrace offers a clean design and a very small footprint. Powered by Analogic, the system provides advanced imaging capabilities on a standardized platform with the widest table top available at 49cm – a feature accommodating bariatric patients weighing up to 660 lbs.
“For radiation therapy practitioners and their patients, the FCT Embrace has an intelligent design that optimally matches the rotational arc of the linear accelerator, offering easy and precise positioning options for simulation, with the benefit of high-resolution images from a 64-slice and above clinical system at low dose levels,” Banner said.
The FCT Embrace is FDA-approved and is installed in one clinical study test site so far.